Brought to you by 
IPO raises $67mm for Anacor
27 Apr 2012
Executive Summary
Anacor Pharmaceuticals Inc. (developing small-molecule therapeutics using its boron chemistry platform) has raised $67mm through its initial public offering of 13.38mm common shares (including the overallotment) priced at $5 each, down from the $16-18 per share price it was hoping for.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IPO raises $67mm for Anacor
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice